397 related articles for article (PubMed ID: 22727921)
1. Markers of visceral obesity and cardiovascular risk in patients with polycystic ovarian syndrome.
Gateva AT; Kamenov ZA
Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):161-6. PubMed ID: 22727921
[TBL] [Abstract][Full Text] [Related]
2. Anthropometric indices of central obesity how discriminators of metabolic syndrome in Brazilian women with polycystic ovary syndrome.
Costa EC; Sá JC; Soares EM; Lemos TM; Maranhão TM; Azevedo GD
Gynecol Endocrinol; 2012 Jan; 28(1):12-5. PubMed ID: 21958393
[TBL] [Abstract][Full Text] [Related]
3. Waist circumference and BMI cut-off points to predict risk factors for metabolic syndrome among outpatients in a district hospital.
Aye M; Sazali M
Singapore Med J; 2012 Aug; 53(8):545-50. PubMed ID: 22941134
[TBL] [Abstract][Full Text] [Related]
4. High sensitive serum C-reactive protein and its relationship with other cardiovascular risk factors in normoinsulinemic polycystic ovary patients without metabolic syndrome.
Verit FF
Arch Gynecol Obstet; 2010 Jun; 281(6):1009-14. PubMed ID: 19771438
[TBL] [Abstract][Full Text] [Related]
5. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
Rees E; Coulson R; Dunstan F; Evans WD; Blundell HL; Luzio SD; Dunseath G; Halcox JP; Fraser AG; Rees DA
Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
[TBL] [Abstract][Full Text] [Related]
6. Optimal waist circumference for prediction of metabolic syndrome in young Korean women with polycystic ovary syndrome.
Oh JY; Sung YA; Lee HJ; Oh JY; Chung HW; Park H
Obesity (Silver Spring); 2010 Mar; 18(3):593-7. PubMed ID: 19763092
[TBL] [Abstract][Full Text] [Related]
7. Lipid accumulation product index: a reliable marker of cardiovascular risk in polycystic ovary syndrome.
Wiltgen D; Benedetto IG; Mastella LS; Spritzer PM
Hum Reprod; 2009 Jul; 24(7):1726-31. PubMed ID: 19329517
[TBL] [Abstract][Full Text] [Related]
8. Waist circumference predicts increased cardiometabolic risk in normal weight adolescent males.
Taylor SA; Hergenroeder AC
Int J Pediatr Obes; 2011 Jun; 6(2-2):e307-11. PubMed ID: 21649469
[TBL] [Abstract][Full Text] [Related]
9. Obesity indices and major components of metabolic syndrome in young adult Arab subjects.
Al-Shayji IA; Akanji AO
Ann Nutr Metab; 2004; 48(1):1-7. PubMed ID: 14639040
[TBL] [Abstract][Full Text] [Related]
10. Lipid accumulation product is related to metabolic syndrome in women with polycystic ovary syndrome.
Xiang S; Hua F; Chen L; Tang Y; Jiang X; Liu Z
Exp Clin Endocrinol Diabetes; 2013 Feb; 121(2):115-8. PubMed ID: 23426706
[TBL] [Abstract][Full Text] [Related]
11. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
[TBL] [Abstract][Full Text] [Related]
12. NT-proBNP levels in premenopausal women with polycystic ovarian syndrome and/or obesity.
Gateva A; Kamenov Z; Tsakova A
J Obstet Gynaecol; 2013 Nov; 33(8):868-72. PubMed ID: 24219732
[TBL] [Abstract][Full Text] [Related]
13. Relation between C-reactive protein and body mass index in patients with polycystic ovarian syndrome.
Moradi S; Mollabashi M; Kerman SR
Gynecol Endocrinol; 2011 Jul; 27(7):480-5. PubMed ID: 20836727
[TBL] [Abstract][Full Text] [Related]
14. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
15. Emergence of ovulatory cycles with aging in women with polycystic ovary syndrome (PCOS) alters the trajectory of cardiovascular and metabolic risk factors.
Carmina E; Campagna AM; Lobo RA
Hum Reprod; 2013 Aug; 28(8):2245-52. PubMed ID: 23595974
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of insulin resistance and metabolic syndrome in patients with polycystic ovary syndrome.
Lankarani M; Valizadeh N; Heshmat R; Peimani M; Sohrabvand F
Gynecol Endocrinol; 2009 Aug; 25(8):504-7. PubMed ID: 19499403
[TBL] [Abstract][Full Text] [Related]
17. Metabolically healthy polycystic ovary syndrome (MH-PCOS) and metabolically unhealthy polycystic ovary syndrome (MU-PCOS): a comparative analysis of four simple methods useful for metabolic assessment.
Amato MC; Guarnotta V; Forti D; Donatelli M; Dolcimascolo S; Giordano C
Hum Reprod; 2013 Jul; 28(7):1919-28. PubMed ID: 23592224
[TBL] [Abstract][Full Text] [Related]
18. [Exploration of the classification of polycystic ovarian syndrome].
Lin JF; Li X; Zhu MW
Zhonghua Fu Chan Ke Za Zhi; 2006 Oct; 41(10):684-8. PubMed ID: 17199924
[TBL] [Abstract][Full Text] [Related]
19. Estimation of truncal adiposity using waist circumference or the sum of trunk skinfolds: a pilot study for insulin resistance screening in hirsute patients with or without polycystic ovary syndrome.
Toscani M; Migliavacca R; Sisson de Castro JA; Spritzer PM
Metabolism; 2007 Jul; 56(7):992-7. PubMed ID: 17570263
[TBL] [Abstract][Full Text] [Related]
20. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
